Outcomes Study: Evaluating Health Literacy and Disease Activity in Patients with Rheumatoid Arthritis

All Posts

Outcomes Study: Evaluating Health Literacy and Disease Activity in Patients with Rheumatoid Arthritis

Members of our team had the opportunity to present a new poster abstract at the NASP 2024 Annual Meeting held October 6 – 9.

 

Authors

Brooke Stephen, PharmD Candidate 2025 | Anthony DeAngelis III, PharmD, CSP | Carly Giavatto, PharmD | Casey Fitzpatrick, PharmD, BCPS | Andrew Wash, PharmD, PhD | Ana I. Lopez-Medina, PharmD, PhD ​| Amber Skrtic, PharmD, CSP, AAHIVP | Jami Schell, PharmD | Jessica Mourani, PharmD 

 

Background

  • Health literacy is a critical component of one’s health care status as patients with limited health literacy have difficulties managing chronic conditions, poor adherence, and, consequently, higher rates of hospitalization.1,2
  • For patients with rheumatoid arthritis (RA), research has revealed that patients with higher health literacy have a better understanding of their disease state compared to patients with lower health literacy.3
  • The health-system specialty pharmacy (HSSP) model has been shown to improve medication access, adherence, and persistence, resulting in optimized clinical outcomes.4
  • Patient-reported outcome measures (PROMs) are increasingly being utilized in HSSP practice to assess patients’ experiences and health status to aid in clinical decision making.

Objectives

  • The purpose of this study is to evaluate the relationship between health literacy and the change in patient-reported RA disease activity after treatment initiation.

 

Read about the team’s findings by downloading the outcomes study below.

 

Submit your contact information below to receive insights from our team of pharmacy solutions experts.